Shengnan Xia

1.6k total citations
69 papers, 956 citations indexed

About

Shengnan Xia is a scholar working on Neurology, Immunology and Molecular Biology. According to data from OpenAlex, Shengnan Xia has authored 69 papers receiving a total of 956 indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Neurology, 21 papers in Immunology and 19 papers in Molecular Biology. Recurrent topics in Shengnan Xia's work include Neuroinflammation and Neurodegeneration Mechanisms (38 papers), Neurological Disease Mechanisms and Treatments (22 papers) and Immune cells in cancer (11 papers). Shengnan Xia is often cited by papers focused on Neuroinflammation and Neurodegeneration Mechanisms (38 papers), Neurological Disease Mechanisms and Treatments (22 papers) and Immune cells in cancer (11 papers). Shengnan Xia collaborates with scholars based in China and United States. Shengnan Xia's co-authors include Xinyu Bao, Yun Xu, Xiang Cao, Pinyi Liu, Siyi Xu, Shu Shu, Shiji Deng, Yun Xu, Yue Gu and Yue Gu and has published in prestigious journals such as Nature Communications, Scientific Reports and PLoS Biology.

In The Last Decade

Shengnan Xia

64 papers receiving 949 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shengnan Xia China 19 413 384 184 120 85 69 956
Yong Luo China 21 238 0.6× 326 0.8× 107 0.6× 122 1.0× 47 0.6× 73 1.2k
Xiangyu Zheng China 16 219 0.5× 318 0.8× 197 1.1× 64 0.5× 210 2.5× 42 1.1k
Shenbin Xu China 14 495 1.2× 373 1.0× 226 1.2× 93 0.8× 109 1.3× 21 1.1k
Mei Yuanwu China 19 243 0.6× 300 0.8× 86 0.5× 59 0.5× 118 1.4× 41 867
Hong Fan China 20 352 0.9× 564 1.5× 254 1.4× 90 0.8× 224 2.6× 44 1.3k
Choong‐Hyun Lee South Korea 19 244 0.6× 318 0.8× 57 0.3× 134 1.1× 175 2.1× 79 1.1k
Gourav Roy Choudhury United States 16 396 1.0× 435 1.1× 125 0.7× 109 0.9× 210 2.5× 25 1.1k
Marta Lombardi Italy 11 463 1.1× 609 1.6× 198 1.1× 246 2.0× 113 1.3× 15 1.1k
Jinpyo Hong South Korea 18 223 0.5× 481 1.3× 162 0.9× 87 0.7× 256 3.0× 34 1.1k

Countries citing papers authored by Shengnan Xia

Since Specialization
Citations

This map shows the geographic impact of Shengnan Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shengnan Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shengnan Xia more than expected).

Fields of papers citing papers by Shengnan Xia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shengnan Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shengnan Xia. The network helps show where Shengnan Xia may publish in the future.

Co-authorship network of co-authors of Shengnan Xia

This figure shows the co-authorship network connecting the top 25 collaborators of Shengnan Xia. A scholar is included among the top collaborators of Shengnan Xia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shengnan Xia. Shengnan Xia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xia, Shengnan, Susumu Antoku, David Chen, et al.. (2025). The spatial landscape of glial pathology and T cell response in Parkinson’s disease substantia nigra. Nature Communications. 16(1). 7146–7146. 3 indexed citations
2.
Yang, Lixuan, Geng Yang, Shengnan Xia, et al.. (2025). Loss of Plxdc2 exacerbates microglia-mediated neuroinflammation and ischemic brain injury. Experimental Neurology. 391. 115302–115302. 2 indexed citations
3.
Zhang, Ran, Jing Xiao, Ying Liang, et al.. (2025). Neuroprotective Effects of Eugenol Acetate Against Ischemic Stroke. Journal of Inflammation Research. Volume 18. 133–146.
4.
Zhu, Liwen, Chao Zhou, Huiya Li, et al.. (2025). Microglial CARD19 ameliorates post-stroke neuroinflammation by stabilizing mitochondrial cristae. Neural Regeneration Research.
5.
Liang, Ying, Jing Huang, Shengnan Xia, et al.. (2024). Neuroprotective effects of Aucubin against cerebral ischemia–reperfusion injury. International Immunopharmacology. 129. 111648–111648. 4 indexed citations
6.
Zhang, Yuxin, Lixuan Yang, Chenchen Zhao, et al.. (2024). Benzydamine attenuates microglia-mediated neuroinflammation and ischemic brain injury by targeting cathepsin s. International Immunopharmacology. 146. 113824–113824. 1 indexed citations
7.
Li, Chenggang, Yuhao Xu, Xiang Cao, et al.. (2024). Xiangshao Granules Ameliorate Post-stroke Depression by Inhibiting Activation of Microglia and IDO1 Expression in Hippocampus and Prefrontal Cortex. Chinese Journal of Integrative Medicine. 31(1). 28–38. 3 indexed citations
8.
Chen, Yuxin, et al.. (2023). Evaluation of fusion performances of skin wound incisions under different defocus amounts in laser tissue welding. Optics & Laser Technology. 165. 109570–109570. 9 indexed citations
9.
Liu, Pinyi, Siyi Xu, Shengnan Xia, et al.. (2023). Infiltrating myeloid cell-derived properdin markedly promotes microglia-mediated neuroinflammation after ischemic stroke. Journal of Neuroinflammation. 20(1). 260–260. 10 indexed citations
10.
Li, Jiangnan, Xinxin Zou, Rui Mao, et al.. (2023). Determination of the role of hippocampal astrocytes in the bilateral common carotid artery stenosis mouse model by RNA sequencing. Neuroscience Letters. 805. 137213–137213. 4 indexed citations
11.
Cao, Qian, Shengnan Xia, Xiang Cao, et al.. (2023). A newly-synthesized compound CP-07 alleviates microglia-mediated neuroinflammation and ischemic brain injury via inhibiting STAT3 phosphorylation. Journal of Translational Internal Medicine. 11(2). 156–168. 22 indexed citations
12.
Zhang, Zhi, Xin Shu, Qian Cao, et al.. (2023). Compound from Magnolia officinalis Ameliorates White Matter Injury by Promoting Oligodendrocyte Maturation in Chronic Cerebral Ischemia Models. Neuroscience Bulletin. 39(10). 1497–1511. 12 indexed citations
13.
Jia, Junqiu, Lili Zheng, Lei Ye, et al.. (2023). CD11c+ microglia promote white matter repair after ischemic stroke. Cell Death and Disease. 14(2). 156–156. 50 indexed citations
14.
Chen, Weimin, et al.. (2023). The current status and development of DC/AC inverter technology. Highlights in Science Engineering and Technology. 43. 527–536. 1 indexed citations
15.
Cao, Qian, Jian Chen, Zhi Zhang, et al.. (2023). Astrocytic CXCL5 hinders microglial phagocytosis of myelin debris and aggravates white matter injury in chronic cerebral ischemia. Journal of Neuroinflammation. 20(1). 105–105. 33 indexed citations
16.
Deng, Shiji, Shengnan Xia, Xinyu Bao, et al.. (2022). Fraxetin alleviates microglia-mediated neuroinflammation after ischemic stroke. Annals of Translational Medicine. 10(8). 439–439. 19 indexed citations
17.
Zhuang, Xinyu, Shengnan Xia, Zhiqiang Xu, et al.. (2022). R848 Adjuvant Laden With Self-Assembled Nanoparticle-Based mRNA Vaccine Elicits Protective Immunity Against H5N1 in Mice. Frontiers in Immunology. 13. 836274–836274. 15 indexed citations
18.
Liu, Ying, Shiji Deng, Zhi Zhang, et al.. (2020). 6-Gingerol attenuates microglia-mediated neuroinflammation and ischemic brain injuries through Akt-mTOR-STAT3 signaling pathway. European Journal of Pharmacology. 883. 173294–173294. 46 indexed citations
19.
Zhang, Shuai, Hongmei Zhao, Shengnan Xia, et al.. (2020). MicroRNA-153 impairs presynaptic plasticity by blocking vesicle release following chronic brain hypoperfusion. Cell Communication and Signaling. 18(1). 57–57. 33 indexed citations
20.
Chen, Zhifang, Xiao Li, Jingjing Zhou, et al.. (2017). Accumulated quiescent neural stem cells in adult hippocampus of the mouse model for the MECP2 duplication syndrome. Scientific Reports. 7(1). 41701–41701. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026